Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Tim Townes, PhD
Researcher Professor Emeritus
Department of Biochemistry & Molecular Genetics
The University of Alabama at Birmingham
Shelby Biomedical Research Building
Room 707
1825 University Blvd.
Birmingham, Alabama, United States
Tim M. Townes (b.1951), Professor and Chairman of Biochemistry and Molecular Genetics, received his BS degree in 1973, an M.S. degree in Zoology in 1975, and a Ph.D. degree in Microbiology in 1980 from the University of Tennessee. After completing his graduate studies, he joined Dr. Jerry Lingrel’s group at the University of Cincinnati, where he studied globin gene expression in goats and transgenic mice. He joined the UAB faculty in 1984. His research is supported by grants from NIH.
The major interest of his laboratory is the regulation of gene expression during development. They study the human hemoglobin genes as a model system and translate their understanding of basic mechanisms of globin gene regulation into strategies to correct hemoglobinopathies such as beta-thalassemia and sickle cell disease.
Dr Townes’ work focuses on the following 4 areas:
(1) Globin gene switching during development
(2) Locus Control Region regulation of chromatin structure and gene expression
(3) Genetic modifiers of sickle cell disease severity and
(4) Genetic therapies to correct beta-thalassemia and sickle cell disease.
+myBinderRelated Content
-
The Association Between Timely Opioid Administration and Hospitalization in Children With Sickle Cell Disease Presen...Objective: To evaluate the association ...
-
Pediatric to adult care co-location transitional model for youth with sickle cell diseaseSurvival to adulthood for children with ...
-
George Buchanan, MDDr. George R. Buchanan is a Professor of...
-
SCDAA And MedicAlert Pilot Program ApplicationSCDAA and MedicAlert Pilot Program Impr...
-
Four Solutions for Sickle Cell Disease SupportWhen Precious Lee was a year old, she be...
-
Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients Wi...Sancilio Pharmaceuticals Company, Inc. (...
-
Sylvia Benjamin, MB, BS, FRCP, FRCPathSylvia Benjamin is Consultant in Haemato...
